RankAlpha logo
Back to Rankings

CABA

Cabaletta BioD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
EULAR data support continued clinical momentum, including durable immunomodulator-free responses, a possible second pivotal SSc program, and a broader PC-free market opportunity. The May financing and Cellares manufacturing agreement improve development capacity.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -6.5.
What can break
Cellares manufacturing scale-up and outpatient delivery assumptions remain execution-dependent.
Momentum
64
Value
41
Sentiment
45
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $2.50 · Bull $4.50 · Bear $1.25Analysis 2026-08-08; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-08 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-09-09

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions

Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $13.25
Why
Momentum64 · Δ7d +16.2
Value41 · Δ7d 0.0
Sentiment45 · Δ7d -6.5
So what
Weak posture (Net Neutral). Prioritize risk control and patience.

Confirming evidence

  • Sentiment remains the lead driver in the composite, 7D delta -6.5.

Contradictions & invalidation

  • Cellares manufacturing scale-up and outpatient delivery assumptions remain execution-dependent.
  • Early clinical response and biomarker data may not translate into durable efficacy or positive registrational outcomes.
  • The deterministic update is negative, and the scheduled August 5 earnings follow-up could not be confirmed with a new company release, 8-K, or transcript in the bounded check.

Catalyst clock

2026-12-31

SSc registrational program initiation anticipated in 4Q26

Lead driver: Sentiment · See AI snapshot
Momentum
64
9% active weight
Current posture
7d trendSoftening
Δ7d
+16.2
Δ21d
+47.9
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
45
62% active weight
Current posture
7d trendSoftening
Δ7d
-6.5
Δ21d
-34.7
Why this grade

Composite grade D. Momentum 63.6 / Value 41.2 / Sentiment 44.6

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-08. Scenario method

B+
Bull case
20%
Probability
Target price
$4.50
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
Most likely
B
Base case
45%
Probability
Target price
$2.50
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$1.25
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$489.99M
Beta
3.26
Shares Out
169.55M
P/E (TTM) · Derived
-1.4
P/S (TTM)
-
P/FCF (TTM) · Derived
-2.15
Rev YoY
-
EPS YoY
-53.7%
Gross Margin
-
Op Margin
-
Net Debt
-$106.5M
Current Ratio
5.79
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data